Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 1
2009 2
2010 1
2011 1
2014 1
2015 1
2016 1
2017 2
2018 2
2019 4
2020 1
2021 7
2022 4
2023 4
2024 8
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
The immunology of Epstein-Barr virus-induced disease.
Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. Taylor GS, et al. Among authors: brooks jm. Annu Rev Immunol. 2015;33:787-821. doi: 10.1146/annurev-immunol-032414-112326. Epub 2015 Feb 11. Annu Rev Immunol. 2015. PMID: 25706097 Review.
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
Mehanna H, Taberna M, von Buchwald C, Tous S, Brooks J, Mena M, Morey F, Grønhøj C, Rasmussen JH, Garset-Zamani M, Bruni L, Batis N, Brakenhoff RH, Leemans CR, Baatenburg de Jong RJ, Klussmann JP, Wuerdemann N, Wagner S, Dalianis T, Marklund L, Mirghani H, Schache A, James JA, Huang SH, O'Sullivan B, Nankivell P, Broglie MA, Hoffmann M, Quabius ES, Alemany L; HNCIG-EPIC group. Mehanna H, et al. Among authors: brooks j. Lancet Oncol. 2023 Mar;24(3):239-251. doi: 10.1016/S1470-2045(23)00013-X. Epub 2023 Feb 13. Lancet Oncol. 2023. PMID: 36796393 Free article.
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group. Mehanna H, et al. Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449623 Free PMC article. Clinical Trial.
TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma.
von Buchwald C, Jakobsen KK, Carlander AF, Tous S, Grønhøj C, Rasmussen JH, Brooks J, Taberna M, Mena M, Morey F, Bruni L, Batis N, Brakenhoff RH, René Leemans C, Jong RJB, Klussmann JP, Wuerdemann N, Wagner S, Dalianis T, Marklund L, Mirghani H, Schache A, James JA, Huang SH, O'Sullivan B, Nankivell P, Broglie MA, Hoffmann M, Quabius ES, Anderson LA, Craig SG, Alemany L, Mehanna H; HNCIG-EPIC group. von Buchwald C, et al. Among authors: brooks j. Eur J Cancer. 2024 Nov;211:114329. doi: 10.1016/j.ejca.2024.114329. Epub 2024 Sep 12. Eur J Cancer. 2024. PMID: 39293346
Big-data approaches lead to an increased understanding of the ecology of animal movement.
Nathan R, Monk CT, Arlinghaus R, Adam T, Alós J, Assaf M, Baktoft H, Beardsworth CE, Bertram MG, Bijleveld AI, Brodin T, Brooks JL, Campos-Candela A, Cooke SJ, Gjelland KØ, Gupte PR, Harel R, Hellström G, Jeltsch F, Killen SS, Klefoth T, Langrock R, Lennox RJ, Lourie E, Madden JR, Orchan Y, Pauwels IS, Říha M, Roeleke M, Schlägel UE, Shohami D, Signer J, Toledo S, Vilk O, Westrelin S, Whiteside MA, Jarić I. Nathan R, et al. Among authors: brooks jl. Science. 2022 Feb 18;375(6582):eabg1780. doi: 10.1126/science.abg1780. Epub 2022 Feb 18. Science. 2022. PMID: 35175823 Review.
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study.
Mehanna H, Rapozo D, von Zeidler SV, Harrington KJ, Winter SC, Hartley A, Nankivell P, Schache AG, Sloan P, Odell EW, Thavaraj S, Hunter KD, Shah KA, Thomas GJ, Long A, Amel-Kashipaz R, Brown RM, Conn B, Hall GL, Matthews P, Weir J, Yeo Y, Pring M, West CML, McCaul J, Golusinski P, Sitch A, Spruce R, Batis N, Bryant JL, Brooks JM, Jones TM, Buffa F, Haider S, Robinson M. Mehanna H, et al. Among authors: brooks jm. Clin Cancer Res. 2024 Jan 17;30(2):356-367. doi: 10.1158/1078-0432.CCR-23-1013. Clin Cancer Res. 2024. PMID: 37870417 Free PMC article.
41 results